Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib.

@article{Vitale2016AutoimmuneCI,
  title={Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib.},
  author={Candida Vitale and Inhye E. Ahn and Mariela Sivina and Alessandra Ferrajoli and William G Wierda and Zeev Estrov and Sergej Naumovich Konoplev and Nitin Jain and Susan M O'Brien and Mohammed Z. H. Farooqui and Michael J. Keating and Adrian Wiestner and Jan A Burger},
  journal={Haematologica},
  year={2016},
  volume={101 6},
  pages={
          e254-8
        }
}
  • Candida Vitale, Inhye E. Ahn, +10 authors Jan A Burger
  • Published in Haematologica 2016
  • Medicine
  • Autoimmune cytopenias (AIC) are common in chronic lymphocytic leukemia (CLL) and include autoimmune hemolytic anemia, immune thrombocytopenia and, less frequently, pure red blood cell aplasia. It is generally accepted that treatment of CLL-associated AIC should be primarily directed against the 

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Tables and Topics from this paper.

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 17 CITATIONS

    How I treat autoimmune hemolytic anemia.

    VIEW 3 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Chronic Lymphocytic Leukemia: Diagnosis and Treatment.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 14 REFERENCES

    Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia.